U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H5I3NO3.Na
Molecular Weight 578.8441
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ACETRIZOATE SODIUM

SMILES

[Na+].CC(=O)NC1=C(I)C=C(I)C(C([O-])=O)=C1I

InChI

InChIKey=UCPVOMHRDXMAIZ-UHFFFAOYSA-M
InChI=1S/C9H6I3NO3.Na/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16;/h2H,1H3,(H,13,14)(H,15,16);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C9H5I3NO3
Molecular Weight 555.8543
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.tabletwise.com/brazil/urografina-solution | https://clinicaltrials.gov/ct2/show/NCT01440712 | https://clinicaltrials.gov/ct2/show/NCT01515696 | https://clinicaltrials.gov/ct2/show/NCT00601809

Acetrizoic acid (trade names Gastrografina, Urografina in Portugal) is a palatable lemon-flavored water-soluble iodinated radiopaque X-ray contrast medium for oral or rectal administration only. Acetrizoic acid is indicated for radiographic examination of segments of the gastrointestinal tract (esophagus, stomach, proximal small intestine, and colon). The preparation is particularly indicated when a more viscous agent such as barium sulfate, which is not water-soluble, is not feasible or is potentially dangerous. Administration of hypertonic Gastrografin solutions may lead to hypovolemia and hypotension due to fluid loss from the intestine.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Gastrografina

Approved Use

Unknown
Diagnostic
Gastrografina

Approved Use

Unknown
Diagnostic
Gastrografina

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
248 ng/mL
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ACETRIZOIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: MALE
food status: FASTED
416 ng/mL
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ACETRIZOIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1342 ng × h/mL
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ACETRIZOIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
2.3 h
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ACETRIZOIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: MALE
food status: FASTED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
0.1%
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ACETRIZOIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
TABAC.
1950 Jul-Aug
Patents

Patents

Sample Use Guides

Adult oral dosage may range from 30 to 90 mL (11 to 33 g iodine), depending on the nature of the examination and the size of the patient. For infants and children less than 5 years of age, 30 mL (11 g iodine) are usually adequate; for children 5 to 10 years of age, the suggested dose is 60 mL (22 g iodine).
Route of Administration: Oral
In Vitro Use Guide
Blood was taken from the femoral artery of heparinized dogs (heparin 500 I.U./kg I.V.). Immediately after collection, the blood samples were incubated for 45 sec. at 37 C with the solutions of the ACETRIZOIC ACID;the final concentrations of the contrast media in the incubation medium were 220 mM. This was done by adding to aliquots of whole blood the solutions oЈ contrast media, which were hyperosmolar to plasma (2200 mOsm).
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:32:54 GMT 2023
Edited
by admin
on Sat Dec 16 17:32:54 GMT 2023
Record UNII
5GF4B2I1DD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ACETRIZOATE SODIUM
ORANGE BOOK  
Common Name English
ACETRIZOATE SODIUM SALT
Common Name English
ACETRIZOIC ACID SODIUM SALT [MI]
Common Name English
SODIUM ACETRIZOATE
INN   MART.   WHO-DD  
INN  
Official Name English
SODIUM 3-ACETAMIDO-2,4,6-TRIIODOBENZOATE
Systematic Name English
ACETRIZOATE SODIUM [ORANGE BOOK]
Common Name English
SALPIX
Brand Name English
sodium acetrizoate [INN]
Common Name English
Sodium acetrizoate [WHO-DD]
Common Name English
SODIUM ACETRIZOATE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C390
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
Code System Code Type Description
EVMPD
SUB10546MIG
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
WIKIPEDIA
SODIUM ACETRIZOATE
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
NCI_THESAURUS
C65211
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
SMS_ID
100000083524
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
DRUG BANK
DBSALT001380
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
FDA UNII
5GF4B2I1DD
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
CAS
129-63-5
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
EPA CompTox
DTXSID30926269
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
ECHA (EC/EINECS)
204-956-1
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201327
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
PUBCHEM
23665874
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
MERCK INDEX
m994
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY Merck Index
INN
152
Created by admin on Sat Dec 16 17:32:54 GMT 2023 , Edited by admin on Sat Dec 16 17:32:54 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY